ATLANTA, July 31, 2025 (GLOBE NEWSWIRE) -- Gray Media has named Eric Walters as the next General Manager of KNOE and KAQY-LD, Gray’s CBS and ABC affiliates in Monroe, Louisiana, effective September 1, 2025. Eric is currently General Manager of KMVT (CBS) and KSVT-LD (FOX) in Twin Falls, Idaho. During his tenure, he worked with station leaders to grow ratings in all newscasts and to significantly increase digital content across all platforms. Eric previously served as the News Director of Gray’s WDBJ (CBS ...

Beerse, Belgium – July 31, 2025 – 20:30 CET Campine NV, metals recycling and specialty chemicals company from Beerse, Belgium and listed on Euronext Brussels, navigates in an agile way through the different effects of trade wars. Following the U.S. administration’s announcement on April 2nd, 2025, of new import tariffs for European products, Campine received official confirmation that its antimony trioxide (ATO) is exempt from these duties. This contrasts sharply with the 15% tariffs now applied to most oth ...

Company Overview - GRI Bio, Inc. is a biotechnology company focused on developing Natural Killer T (NKT) cell modulators for treating inflammatory, fibrotic, and autoimmune diseases [3] - The company is in the clinical stage and aims to fundamentally change treatment approaches for these diseases [3] Recent Developments - GRI Bio participated in a Virtual Investor segment where CEO Marc Hertz discussed interim biomarker data from a Phase 2a study in Idiopathic Pulmonary Fibrosis (IPF) [2] - The interim data was collected over a 6-week period, indicating progress in the ongoing study [2] Product Pipeline - GRI Bio's lead program, GRI-0621, is an inhibitor of iNKT cell activity, being developed as an oral therapeutic for IPF, which has significant unmet medical needs [3] - The company is also developing a pipeline of novel type 2 diverse NKT (dNKT) agonists aimed at treating systemic lupus erythematosus [3] - GRI Bio possesses a library of over 500 proprietary compounds, which supports the expansion of its product pipeline [3]

Core Insights - LLYC reported a 15% increase in recurring EBITDA for H1 2025, reaching €7.9 million, with total income growing by 18.9% to €64.8 million [1][7] - The company updated its financial guidance for 2025, expecting operating income between €106 million and €114 million and recurring EBITDA between €19 million and €20.5 million, with an estimated EBITDA margin of around 18% [2] Financial Performance - Operating income increased by 6.1% to €45.8 million, while total income rose nearly 19% to €64.8 million [1][7] - The EBITDA margin improved to 17.2%, up 1.3 percentage points from the previous year, reflecting effective cost management [2] Strategic Initiatives - LLYC acquired a 60% stake in Digital Solvers, enhancing its digital communication capabilities in Brazil, and completed the acquisition of Lambert, solidifying its U.S. market position [4] - The company is focusing on operational efficiency and long-term growth investments, particularly in AI and data processing technologies [5] Innovation and Technology - LLYC launched AI Legislab, an AI-powered platform for legislative information analysis, and is implementing a global solution using generative AI to enhance brand visibility and consistency [5]

Viridien Société Anonyme with a share capital of €7,180,449Registered office: 27 avenue Carnot, 91300 MassyNo.: 969 202 241 – RCS Evry 2025 Interim Financial Report available Paris, France – July 31, 2025 Viridien announced that its interim financial report as at June 30, 2025 was filed today with the Autorité des Marchés Financiers (AMF). This document is available on the Company’s website: https://www.viridiengroup.com/ under the Investors section (both in “Regulated information” and “Results and Publicat ...

July 31st, 2025 RCI Banque: ‘’2025 First Half Business Report is now available’’ The RCI Banque group ‘’2025 First Half Business Report’’ is now available on the Mobilize Financial Services website www.mobilize-fs.com Attachment Press Release - Report activity 2024 ...

Press Release Paris – July 31, 2025 – EUROAPI posted today its 2025 condensed Half-Year Consolidated Financial Statements for the six months ended June 30, 2025. This document is available for consultation and downloading on EUROAPI’s website: https://www.euroapi.com/en/investors/regulatory-information/financial-reports. This report includes notably the 2025 half-year management report, the consolidated financial statements on 30 June 2025, and the Statutory Auditors’ review report on the half-yearly fi ...

Online availability of Sanofi’s half-year financial report for 2025 Paris, July 31, 2025. Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K. This document may be found on the company’s corporate website: www.sanofi.com and downloaded from the “Investors” page, under the heading “Re ...

Core Points - SMCP has made its interim financial report for the six-month period ended June 30, 2025, publicly available and filed with the Autorité des marchés financiers [2] - The report can be accessed on SMCP's official website under the Finance section [2] Company Overview - SMCP is a global leader in the accessible luxury market, featuring four unique Parisian brands: Sandro, Maje, Claudie Pierlot, and Fursac [2] - The company operates in 55 countries with a network of over 1,600 stores and a strong digital presence in key markets [2] - SMCP is led by CEO Isabelle Guichot and was founded by Evelyne Chetrite and Judith Milgrom, who continue to provide creative direction for Sandro and Maje [2] - Claudie Pierlot and Fursac were acquired by SMCP in 2009 and 2019, respectively [2] - SMCP is listed on the Euronext Paris regulated market, compartment A, with ISIN Code FR0013214145 and ticker SMCP [2]

EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal third quarter ended June 30, 2025, before market open on August 14, 2025. Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Thursday, August 14, 2 ...